213 related articles for article (PubMed ID: 28572092)
1. Cylindromatosis Tumor Suppressor Protein (CYLD) Deubiquitinase is Necessary for Proper Ubiquitination and Degradation of the Epidermal Growth Factor Receptor.
Sanchez-Quiles V; Akimov V; Osinalde N; Francavilla C; Puglia M; Barrio-Hernandez I; Kratchmarova I; Olsen JV; Blagoev B
Mol Cell Proteomics; 2017 Aug; 16(8):1433-1446. PubMed ID: 28572092
[TBL] [Abstract][Full Text] [Related]
2. Data on mass spectrometry-based proteomics for studying the involvement of CYLD in the ubiquitination events downstream of EGFR activation.
Sanchez-Quiles V; Osinalde N; Akimov V; Kratchmarova I; Blagoev B
Data Brief; 2018 Jun; 18():1856-1863. PubMed ID: 29904688
[TBL] [Abstract][Full Text] [Related]
3. Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.
Wisniewski DJ; Liyasova MS; Korrapati S; Zhang X; Ratnayake S; Chen Q; Gilbert SF; Catalano A; Voeller D; Meerzaman D; Guha U; Porat-Shliom N; Annunziata CM; Lipkowitz S
J Biol Chem; 2023 Jan; 299(1):102766. PubMed ID: 36470425
[TBL] [Abstract][Full Text] [Related]
4. αPIX Is a Trafficking Regulator that Balances Recycling and Degradation of the Epidermal Growth Factor Receptor.
Kortüm F; Harms FL; Hennighausen N; Rosenberger G
PLoS One; 2015; 10(7):e0132737. PubMed ID: 26177020
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
6. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
7. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
[TBL] [Abstract][Full Text] [Related]
8. USP25 Regulates EGFR Fate by Modulating EGF-Induced Ubiquitylation Dynamics.
Niño CA; Wollscheid N; Giangreco G; Maspero E; Polo S
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33202887
[TBL] [Abstract][Full Text] [Related]
9. Impaired degradation followed by enhanced recycling of epidermal growth factor receptor caused by hypo-phosphorylation of tyrosine 1045 in RBE cells.
Gui A; Kobayashi A; Motoyama H; Kitazawa M; Takeoka M; Miyagawa S
BMC Cancer; 2012 May; 12():179. PubMed ID: 22591401
[TBL] [Abstract][Full Text] [Related]
10. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.
Hong SY; Shih YP; Li T; Carraway KL; Lo SH
Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213
[TBL] [Abstract][Full Text] [Related]
11. Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation.
Umebayashi K; Stenmark H; Yoshimori T
Mol Biol Cell; 2008 Aug; 19(8):3454-62. PubMed ID: 18508924
[TBL] [Abstract][Full Text] [Related]
12. Threshold-controlled ubiquitination of the EGFR directs receptor fate.
Sigismund S; Algisi V; Nappo G; Conte A; Pascolutti R; Cuomo A; Bonaldi T; Argenzio E; Verhoef LG; Maspero E; Bianchi F; Capuani F; Ciliberto A; Polo S; Di Fiore PP
EMBO J; 2013 Jul; 32(15):2140-57. PubMed ID: 23799367
[TBL] [Abstract][Full Text] [Related]
13. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
Visser GD; Lill NL
Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
[TBL] [Abstract][Full Text] [Related]
14. Knockout of c-Cbl slows EGFR endocytic trafficking and enhances EGFR signaling despite incompletely blocking receptor ubiquitylation.
Crotchett BLM; Ceresa BP
Pharmacol Res Perspect; 2021 Apr; 9(2):e00756. PubMed ID: 33811466
[TBL] [Abstract][Full Text] [Related]
15. LRRC62 attenuates Toll-like receptor signaling by deubiquitinating TAK1 via CYLD.
Zhang J; Ou J; Wan X
Exp Cell Res; 2019 Oct; 383(1):111497. PubMed ID: 31301291
[TBL] [Abstract][Full Text] [Related]
16. IκB kinase promotes Nrf2 ubiquitination and degradation by phosphorylating cylindromatosis, aggravating oxidative stress injury in obesity-related nephropathy.
Chen YY; Hong H; Lei YT; Zou J; Yang YY; He LY
Mol Med; 2021 Oct; 27(1):137. PubMed ID: 34711178
[TBL] [Abstract][Full Text] [Related]
17. CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.
Douanne T; André-Grégoire G; Thys A; Trillet K; Gavard J; Bidère N
Cell Rep; 2019 May; 27(6):1657-1665.e4. PubMed ID: 31067453
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
19. Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains.
Elliott PR; Leske D; Wagstaff J; Schlicher L; Berridge G; Maslen S; Timmermann F; Ma B; Fischer R; Freund SMV; Komander D; Gyrd-Hansen M
Cell Rep; 2021 Oct; 37(1):109777. PubMed ID: 34610306
[TBL] [Abstract][Full Text] [Related]
20. GAPex-5 mediates ubiquitination, trafficking, and degradation of epidermal growth factor receptor.
Su X; Kong C; Stahl PD
J Biol Chem; 2007 Jul; 282(29):21278-84. PubMed ID: 17545148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]